InvestorsHub Logo
Followers 24
Posts 3808
Boards Moderated 0
Alias Born 02/04/2013

Re: geocappy1 post# 184064

Thursday, 07/24/2014 12:29:13 AM

Thursday, July 24, 2014 12:29:13 AM

Post# of 346055
I see a lot of posts about PPHM and Gabrilovich; however, there is not much about Gabrilovich and Peregrine Pharmaceuticals. Even according to PPHM, the scientific advisors seemed to have joined to help guide them in the development of Bavituximab. I don't know if preaching about Bavituximab or PPHM would fall under the "Development" Category. Maybe it does but so far, I have not seen anything to show it does.

I wonder if Gabrilovich actually uses the words "Peregrine Pharmaceuticals" or "Bavituximab" in any of his presentations.

With recent scientific insights highlighting bavituximab's immunostimulatory mechanism of action, Peregrine announced today the following additions to its Scientific Advisory Board. The company plans to utilize the expertise of its new advisors to help guide the development of its novel immunotherapeutic candidate bavituximab:

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News